Blog

La metformina podría utilizarse para tratar la enfermedad de Huntington

La enfermedad de Huntington (HD) es una patología hereditaria y degenerativa, producida por una expansión del triplete CAG (citosina, adenina y guanina) en el primer exón del gen HTT que codifica la proteína huntingtina. Cuando estas expansiones se repiten 36 veces o más, los pacientes sufren neurodegeneración. Esta enfermedad minoritaria

Leer más

New European In Vitro Diagnostic Medical Devices Regulation

There are only 3 weeks left until the implementation of the new European Regulation on In Vitro Diagnostic Medical Devices, which aims to create a safer, more transparent, reliable and predictable environment for these products.  For us as manufacturers, this new regulation is good news as, for the first time, the requirements

Leer más

14th November – World Diabetes Day

Yesterday, the 14th of November, was the World Diabetes Day, celebrated on the day of the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922. This day has been commemorated since 1991, in response to growing concerns about the escalating health threat posed by diabetes.

Leer más

July – Fragile Awareness Month

July is Fragile X Syndrome Awareness Month! In addition, yesterday we celebrated the Fragile X Awareness Day, and for this reason, we would like to share with you a Q&A section that we have prepared about our Fragile X Syndrome Kits of the Adellgene product line. Here are some of

Leer más

28th February – Rare Disease Day

A rare disease is defined as a disease that affects fewer than 1 in 2.000 people. However, despite of X Fragile Syndrome (FXS) being a rare disease, it is the first cause of inherited intellectual disability. For this reason, we want to focus on this pathology. Fragile X Syndrome is

Leer más